1. Nasri Nasrabadi, Parinaz, Martin, Danick, Gharib, Ehsan, Robichaud, Gilles A. 2022. The Pleiotropy of PAX5 Gene Products and Function. In International journal of molecular sciences, 23, . doi:10.3390/ijms231710095. https://pubmed.ncbi.nlm.nih.gov/36077495/
2. Hosokawa, Kohei, Ishimaru, Hanako, Watanabe, Tadashi, Fujimuro, Masahiro. 2021. Pax5 mediates the transcriptional activation of the CD81 gene. In Scientific reports, 11, 22919. doi:10.1038/s41598-021-02082-9. https://pubmed.ncbi.nlm.nih.gov/34824296/
3. Chiorazzi, Nicholas, Chen, Shih-Shih, Rai, Kanti R. 2021. Chronic Lymphocytic Leukemia. In Cold Spring Harbor perspectives in medicine, 11, . doi:10.1101/cshperspect.a035220. https://pubmed.ncbi.nlm.nih.gov/32229611/
4. Carotta, Sebastian, Holmes, Melissa L, Pridans, Clare, Nutt, Stephen L. 2006. Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation. In Cell cycle (Georgetown, Tex.), 5, 2452-6. doi:. https://pubmed.ncbi.nlm.nih.gov/17102626/
5. Fouad, Fatma Mohamed, Eid, Jehane I. . PAX5 fusion genes in acute lymphoblastic leukemia: A literature review. In Medicine, 102, e33836. doi:10.1097/MD.0000000000033836. https://pubmed.ncbi.nlm.nih.gov/37335685/
6. Puente, Xose S, Beà, Silvia, Valdés-Mas, Rafael, López-Otín, Carlos, Campo, Elías. 2015. Non-coding recurrent mutations in chronic lymphocytic leukaemia. In Nature, 526, 519-24. doi:10.1038/nature14666. https://pubmed.ncbi.nlm.nih.gov/26200345/
7. Kurimoto, Keisuke, Hayashi, Masamichi, Guerrero-Preston, Rafael, Fujiwara, Michitaka, Kodera, Yasuhiro. 2017. PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma. In Epigenetics, 12, 865-874. doi:10.1080/15592294.2017.1365207. https://pubmed.ncbi.nlm.nih.gov/29099287/
智鼠故事 
